COVID-19 immunotherapy: Treatment based on the immune cell-mediated approaches-Reference-Cited by-同舟云学术

COVID-19 immunotherapy: Treatment based on the immune cell-mediated approaches

Published:2022-06 Issue: Volume:107 Page:108655
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Zavvar Mahdi,Yahyapoor Aisan,Baghdadi Hamed,Zargaran Sina,Assadiasl Sara,Abdolmohammadi Kamal,Hossein Abooei Amir,Reza Sattarian Mohammad,JalaliFarahani Melina,Zarei Negar,Farahvash Amirali,Fatahi Yousef,Deniz Gunnur,Zarebavani Mitra,Nicknam Mohammad Hossein

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference115 articles.

1. SARS-Cov-2 and COVID-19, Basic and Clinical Aspects of the Human Pandemic: A Review;Zavva;Iran J Public Health.,2021

2. COVID-19: Significance of antibodies;Assadiasl;Hum Antibodies,2020

3. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China;Zhang;Clin Immunol,2020

4. Adoptive Treg cell-based immunotherapy: Frontier therapeutic aspects in rheumatoid arthritis;Zavvar;Immunotherapy,2020

5. A pilot clinical trial of HIV antigen-pulsed allogeneic and autologous dendritic cell therapy in HIV-infected patients;Kundu;AIDS research and human retroviruses,1998

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive Review of COVID-19: Epidemiology, Pathogenesis, Advancement in Diagnostic and Detection Techniques, and Post-Pandemic Treatment Strategies;International Journal of Molecular Sciences;2024-07-26

2. Developing CAR-immune cell therapy against SARS-CoV-2: Current status, challenges and prospects;Biochemical Pharmacology;2024-04

3. A generalizable and easy-to-use COVID-19 stratification model for the next pandemic via immune-phenotyping and machine learning;Frontiers in Immunology;2024-03-27

4. Evaluation of the Polysaccharide “Immeran” Activity in Syrian hamsters’ Model of SARS-CoV-2;Viruses;2024-03-09

5. Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia and/or lymphopenia (RELEASE NCT04578210);Cytotherapy;2024-01